Stealth BioTherapeutics Corp — Form D
Stealth BioTherapeutics Corp of GRAND CAYMAN, E9, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-13. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-04-13
- Form: D
- Accession: 0001696396-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 1
- Date of first sale: 2020-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364841
Issuer
- Name: Stealth BioTherapeutics Corp
- CIK: 0001696396
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Address: 190 ELGIN AVENUE, GRAND CAYMAN, E9, KY1-9005
- Phone: 617-600-6888
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Gerald Chan | Director | Monaco, O9 |
| Francis Chen | Director | Fremont, CA |
| Lu Huang | Director | London, X0 |
| Lou Lange | Director | Newton, MA |
| Irene McCarthy | Director | Newton, MA |
| Kevin McLaughlin | Director | Newton, MA |
| Edward Owens | Director | Newton, MA |
| Irene McCarthy | Executive Officer | Newton, MA |
Other filings by this issuer (1)
More